ME Therapeutics Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 18, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Market Capitalization	148	69	-	-
Enterprise Value	146	68	-	-
Last Close Price	5.00	2.75	-	-
PB Ratio	80.34	46.94	-	-
P/TBV Ratio	80.34	46.94	-	-
Debt / Equity Ratio	0.05	-	0.08	-1.46
Quick Ratio	12.01	24.05	4.41	0.57
Current Ratio	12.23	24.45	4.52	0.59
Return on Equity (ROE)	-67.33%	-129.52%	-3327.53%	-
Return on Assets (ROA)	-40.68%	-77.65%	-157.78%	-
Return on Capital (ROIC)	-42.21%	-84.18%	-195.65%	-
Earnings Yield	-0.79%	-1.87%	-	-
Buyback Yield / Dilution	-21.58%	-55.90%	-84.08%	-

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.